Peel Hunt is acting as NOMAD and Broker to Phytopharm on its proposed acquisition of IXICO Limited, as announced on 23 September 2013. IXICO is a leading provider of medical imaging analysis services in the clinical trials market and is expanding into the ‘digital healthcare’ space with products to support dementia diagnosis.
